The University of Kansas Cancer Center, West Clinic

Kansas City, Kansas 66112

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer Metastatic, HER2-positive Breast Cancer, Triple-negative Breast Cancer

Studies at this site

• Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer — Status unconfirmed
• Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer — Stopped early
• Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer — Status unconfirmed